Inogen | INGN - Current Liabilities


Inogen reported $64.94M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Accuray USD 194.61M 2.03M Sep/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 101.56M 15.72M Dec/2025
AtriCure USD 81.52M 3.68M Dec/2025
Baxter International USD 3.69B 723M Mar/2026
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Boston Scientific USD 4.57B 868M Mar/2026
Chart Industries USD 2.13B 90.4M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
Dexcom USD 2.22B 81.3M Mar/2026
Edwards Lifesciences USD 1.81B 225.7M Dec/2025
Globus Medical USD 498.5M 32.54M Dec/2025
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 680.1M 32.4M Dec/2025
Masimo USD 371.6M 1.9M Dec/2025
Medtronic USD 9.5B 440M Dec/2025
Orthofix International USD 161.03M 9.45M Mar/2026
Philips EUR 7.51B 479M Dec/2025
ResMed USD 1.35B 103.1M Mar/2026
Steris USD 922.3M 33.4M Dec/2025
Stryker USD 6.32B 1.48B Mar/2026
Tandem Diabetes Care USD 242.72M 9.82M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
X T L Biopharmaceuticals USD 761K 1.45M Jun/2025
Zimmer Biomet Holdings USD 2.86B 280.6M Mar/2026